![](/img/cover-not-exists.png)
PRO114 EQ-5D UTILITY ESTIMATES FOR PATIENTS WITH SYSTEMIC SCLEROSIS (SSC). INSIGHTS FROM THE FOCUSSCED PHASE III EFFICAY AND SAFETY STUDY OF TOCILIZUMAB.
Orfanos, P., Felizzi, F., Thuresson, P.O.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2444
Date:
November, 2019
File:
PDF, 324 KB
english, 2019